All In Biotech

Free tool

FAERS Monitor: Asmanex Twisthaler

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021067 or its brand name (Asmanex Twisthaler, Mometasone Furoate). Reports on generic versions are filed under their own applications.

Reports

18,509

Serious

9,021

49% of reports

Hospitalization

3,940

Death reported

620

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • no adverse event3,494
  • product quality issue2,952
  • poor quality device used2,546
  • device malfunction1,824
  • dyspnoea1,727
  • drug dose omission1,496
  • asthma1,297
  • drug ineffective1,275
  • cough1,233
  • headache1,147
  • product dose omission issue939
  • fatigue905
  • off label use899
  • wheezing763
  • nausea745

Reports by year received

View as table
YearReports
200457
200557
200665
200795
2008152
2009127
2010150
2011153
2012235
2013268
2014629
20151,030
20161,110
20171,079
20181,673
20191,719
20201,386
20211,559
20221,792
20231,327
20241,137
20251,129
20261,580

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,650 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
poor quality device usedSignal2,546386.0369.9729,809
device malfunctionSignal1,82430.328.950,398
product quality issueSignal2,95225.224.467,598
no adverse eventSignal3,49422.321.770,385
wheezingSignal76314.813.89,704
asthmaSignal1,29713.212.514,499
drug dose omissionSignal1,49610.49.912,639
coughSignal1,2335.04.83,994
product dose omission issueSignal9393.63.41,812
dyspnoeaSignal1,7273.53.33,115
headacheSignal1,1472.12.0661
fatigue9051.31.273
off label use8991.21.122
drug ineffective1,2751.11.012
nausea7451.11.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.